35
📖 Lesson

Basic Neurochemistry-VI

PSYP610 - Neurological Bases of Behavior

๐ŸŽฏ Objectives

To familiarize the students with the:

  • Various NT and their role in the modulation of behaviors ๐Ÿง 
  • Classification of Neurotransmitters ๐Ÿ“Š: Monoamines: Catecholamines ๐Ÿงช and Indoleamine ๐Ÿ’œ, acetylcholine ๐ŸŽฏ, amino acid ๐Ÿงฌ, and Peptide ๐Ÿ”—
  • Neurotransmitter's role in modulation of behaviors and Aberration โš ๏ธ
  • Drugs and Behavior ๐Ÿ’Š๐ŸŽญ
  • Classification of Psychopharmacological substances ๐Ÿ”ฌ
  • Behavioral correlates, Treatment ๐Ÿฉบ
  • Mechanism of synaptic transmission ๐Ÿ“ก

๐Ÿ“š Main Purpose

We continue our discussion on the control and involvement of 5HT in behaviors ๐Ÿ’œ.

๐ŸŽญ 5HT and Behaviors

We will now proceed to discuss the behaviors which are affected, modified changed or controlled by 5HT ๐Ÿงช.

There are some very important behaviors regulated by 5HT ranging from temperature regulation ๐ŸŒก๏ธ to sleep ๐Ÿ˜ด, anxiety ๐Ÿ˜ฐ and depression ๐Ÿ˜ข.

1๏ธโƒฃ ๐ŸŒก๏ธ Temperature Regulation

Temperature regulation is an important motivational behavior dependent on the day and night cycles ๐ŸŒž๐ŸŒ™. If 5HT is injected intraventrically ๐Ÿ’‰ it leads to increased body temperature โฌ†๏ธ๐ŸŒก๏ธ.

๐Ÿ”ฌ Experimental Evidence

PCPA is injected to deplete brain serotonin โฌ‡๏ธ and after this depletion, raphe nuclei are electrically stimulated โšก no rise in body temperature take place ๐Ÿšซ๐ŸŒก๏ธ. The body temperature would otherwise rise with the stimulation of raphe nuclei (increased serotonin, leads to increased body temperature) โฌ†๏ธ.

2๏ธโƒฃ ๐Ÿ‘๏ธ Sensory Perception

5HT involved in producing the heightened sensory and visuomotor hallucinogenic effect of LSD ๐ŸŒ€. We have talked about LSD effects take place through the serotonergic system ๐Ÿงช.

๐Ÿงช PCPA Effects

Injections of PCPA (which depletes brain serotonin) ๐Ÿ’Š, reduced motor activity โฌ‡๏ธ๐Ÿƒ, and reduced emotional reactivity โฌ‡๏ธ๐Ÿ˜ข, but increased sensitivity to pain โฌ†๏ธโš ๏ธ (means that in rats ๐Ÿ€ the electrical current given for a response is much lower - they respond at a lower current with avoidance and other behaviors ๐Ÿƒ).

๐Ÿ’Š Morphine Tolerance

Further, when 5HT levels are decreased โฌ‡๏ธ this slows down the process of tolerance to morphine ๐ŸŒ (tolerance means that the effectiveness of drug dosage is lessened, so the dosage has to be increased to have the same effect of response) ๐Ÿ’‰.

3๏ธโƒฃ ๐Ÿ˜ด Serotonin and Sleep

Evidence for involvement of 5HT in sleep is provided by experiments in which levels of 5HT are increased by administration of:

  • MOAI ๐Ÿ’Š (reduced deactivation)
  • 5HTP ๐Ÿ’Š (increased enzymes)
  • 5HT ๐Ÿ’‰

This treatment leads to an increase in levels of 5HT โฌ†๏ธ and also increase time spent in Slow Wave Sleep (SWS) ๐Ÿ˜ดโฌ†๏ธ. If 5HT is decreased โฌ‡๏ธ then the time spent in SWS is also decreased โฌ‡๏ธ.

๐Ÿ’ค REM Sleep

PCPA administration (depletes/reduces 5HT drastically) ๐Ÿ’Š also leads to reduced Rapid Eye Movement sleep (REM) โฌ‡๏ธ๐Ÿ’ค.

๐Ÿ‘จโ€๐Ÿ”ฌ Jouvet's Research (1973)

Jouvet (1973) ๐Ÿ‘จโ€๐Ÿ”ฌ was the first one to identify the relationship between 5HT and sleep ๐Ÿ˜ด. Jouvet carried out experiments of manipulating raphe nuclei and seeing its effect in cats ๐Ÿฑ. (Why cats are best animals for sleep research as they spend 2/3rd of their life in sleep) ๐Ÿ˜ด.

The electrolytic lesion of the Raphe nuclei โšก led to decreased 5HT โฌ‡๏ธ and decreased time spent in sleep โฌ‡๏ธ๐Ÿ˜ด. Sleep reduced when 5HT was reduced 85% time in sleep was reduced to 20% (insomniac cats!!) ๐Ÿ˜ผโฐ

๐Ÿงช PCPA Experiment

Further when PCPA was injected ๐Ÿ’Š, 1-2 days after injection (when complete depletion of brain 5HT has taken place) increases insomnia followed โฐโŒ. How was this confirmed? โ“ By injections of 5HTP ๐Ÿ’‰ (which increased 5HT and reverses PCPA induced lower levels of 5HT, insomnia induced by PCPA was reversed!) โœ…๐Ÿ˜ด

4๏ธโƒฃ ๐ŸŽญ Other Behaviors

๐Ÿ˜ข a) Depression

5HT appears to be involved in Depression ๐Ÿ˜ข as there is evidence of decreased 5HT and 5HIAA (5HT metabolite) in brains of suicide victims โฌ‡๏ธ (Bourne et al 1968) ๐Ÿ“…. This indicates that in depression 5HT is lower than normal levels (antidepressant such as tricyclics and MOAI also act to increase levels of 5HT) ๐Ÿ’Šโฌ†๏ธ.

๐Ÿ˜ก b) Behavioral Disinhibition

Decreases in 5HT โฌ‡๏ธ leads to a disinhibition of behaviors (reduced controls on behaviors) ๐Ÿšซ, increased impulsivity โšก, increased aggressiveness ๐Ÿ˜ก, and increased suicidal tendencies โš ๏ธ.

โค๏ธ c) Sexual and Reproductive Behaviors

Serotonin is also involved in control of sexual and reproductive behaviors โค๏ธ. PCPA which depletes 5HT ๐Ÿ’Š, increased sex drive in males โฌ†๏ธโ™‚๏ธ. In females โ™€๏ธ, the ovulation cycle is blocked by narcotics; this blockade is removed by administration of 5HT ๐Ÿ’‰โœ….

Thus, we have seen that 5HT is one of the major neurotransmitters ๐Ÿ’œ which influences a wide range of motivational and other behaviors ๐ŸŽญ.

๐ŸŽฏ Acetylcholine: ACH

One of the major neurotransmitters a class by itself ๐ŸŒŸ, as there is no other like this neurotransmitter. This NT has been well known and around since 1920's ๐Ÿ“…. The effects of ACH have been studied in Bioassay and neuromuscular transmission ๐Ÿ’ช (frog muscles contraction when Ach is applied on the muscle in the experimental solution ๐Ÿธ) demonstrated. Ach is used by neurons which terminate on the neuromuscular junction ๐Ÿ”—.

๐Ÿ“œ Historical Background

Since the 1960's there have been studies using enzymatic, gas chromatography, fluorometric and other studies demonstrating the involvement of Ach in brain-behavior modulation ๐Ÿงช. This is classified as an excitatory NT โšก. Excitatory post synaptic Potentials are released in the muscle cell ๐Ÿ’ช.

โšก ACH Effects

ACH has an excitatory effect on the skeletal muscles ๐Ÿ’ชโšก, but it is inhibitory at heart โค๏ธ๐Ÿ›‘ (remember we earlier told you that the location is as important as the classification of the NT for its actions as excitatory or inhibitory neurotransmitter ๐Ÿ“).

ACH is also found to play an active role in brain areas such as hypothalamus ๐Ÿฅ and cerebral cortex ๐Ÿง . It is involved in learning and memory ๐Ÿ“š (known as the memory molecule ๐Ÿงฌ), and Rapid eye Movement sleep ๐Ÿ’ค.

๐Ÿ”ฌ Study Advantages

The study of Ach is easier than other neurotransmitters as it is easy to remove and study outside the brain in petri dish ๐Ÿงซ. The nicotinic receptors ๐Ÿšฌ was the first receptor identified (Agranoff, p205) โœ….

๐Ÿ—บ๏ธ Distribution

Acetylcholine is found in ganglions of the autonomic nervous system ๐Ÿง  and the target organs of parasympathetic nervous system ๐Ÿ’š.

๐Ÿ”“ Two Types of Receptors

๐Ÿšฌ Nicotinic Receptors

The nicotinic ๐Ÿšฌ- which connects the muscle fibers and works through sodium channels ๐Ÿ“ก (these are ionotropic receptors). Curare ๐Ÿ’€, a poison can block the transmission of Ach at neuromuscular joints ๐Ÿšซ. In neuromuscular joints nicotine mimics excitatory effects of ACH โšก.

๐Ÿ„ Muscarinic Receptors

The muscarinic ๐Ÿ„ that are found in the CNS ๐Ÿง  and these use G proteins ๐Ÿงฌ, cyclic AMPs as second messengers ๐Ÿ“ฌ. These are classified as metabotropic receptors. Atropine ๐Ÿ’Š blocks these receptors, this leads to loss of memory ๐Ÿง โŒ (Pinel 2002, p. 95-102) ๐Ÿ“š.

The ACH receptors are known as the cholinergic receptors ๐Ÿ”—.

โš—๏ธ Synthesis

Acetylcholine is synthesized in a catalytic action of cholinesterase ๐Ÿงช on the Co-enzyme A + its acetate ion and Choline ๐Ÿงฌ. It acts to detach acetate ion from co-enzyme A and attach it with choline to form acetylcholine and separate the Co Enzyme A โšก. The Co Enzyme A is found in Vitamin B ๐Ÿ’Š, and choline is broken down from lipids ๐Ÿงˆ and Acetyl is an acetate ion.

Choline is the rate limiting factor of ach โš ๏ธ (no choline, no Ach) ๐Ÿšซ.

๐Ÿ”„ Breakdown

The Ach is further broken down by these enzymes Choline acetyl transferase โš—๏ธ whereby Ach is broken down into choline and acetyl via a process of hydrolysis ๐Ÿ’ง. Half of choline in this chemical action is retrieved and recycled โ™ป๏ธ.

๐Ÿ—บ๏ธ Involvement and Neuroanatomical Sites of ACH

Ach is formed in the cell bodies of the neuron ๐Ÿงฌ and transported to the neuromuscular junctions ๐Ÿ”—. It is released by action potential โšก, crosses over and activates the muscles fiber ๐Ÿ’ช.

๐Ÿ“ I. Locations

  • a) Acetylcholine is found at all neuromuscular junctions ๐Ÿ’ช, autonomic ganglion and parasympathetic systems ๐Ÿ’š
  • b) Hippocampus ๐ŸŒŠ receives Ach input from medial septal nucleus ๐Ÿง 
  • c) Ach projects into the ascending reticular arousal system โฐ
  • d) Involved in Auditory ๐Ÿ‘‚ and Visual systems ๐Ÿ‘๏ธ
  • e) Found in the Caudate nucleus ๐Ÿง 
  • f) Found in Ventral basal hypothalamus ๐Ÿฅ
  • g) In Supraoptic nucleus brain stem ๐Ÿง 
  • h) Ach acts as a sensory transmitter in thermal receptor ๐ŸŒก๏ธ. Pain is produced by directly putting Ach on to a blister on the skin โš ๏ธ.

โš™๏ธ II. Functions

Ach is involved in the:

  • a) Release of catecholamines ๐Ÿงช (works to balance other NT's and has interaction with DA, NE, and 5HT in all functions) โš–๏ธ
  • b) Conduction of signals ๐Ÿ“ก: it acts in the axonal conduction by depolarizing the axon โšก.

๐Ÿ’Š Steps in ACH Synthesis Where Drugs Can Modulate Action

๐Ÿ”ฌ Drugs Affecting Cholinergic Synapses

Step 1๏ธโƒฃ: Synthesis

Ach Synthesis can be blocked by styryl pyridine ๐Ÿ’Š- a derivative ๐Ÿ›‘.

Step 2๏ธโƒฃ: Release

Release of Ach from the presynaptic membrane is:

  • Enhanced by: ฮฒ-bungarotoxin ๐Ÿ and black widow spider venom ๐Ÿ•ท๏ธ โฌ†๏ธ
  • Blocked by: botulinus toxin ๐Ÿ’€- deadly food poison. The latter acts to block Ach transmission leading to total paralysis โšกโŒ๐Ÿ’ช

Step 3๏ธโƒฃ: Post Receptor Sites

Post receptor sites can be activated or blocked in both type of receptors ๐ŸŽฏ. These are activated by Ach agonists or cholinomimetic drugs โšก and anticholinesterases (blocking the enzyme which breaks down Ach) ๐Ÿ›‘.

๐Ÿšฌ a) Nicotinic Receptors

Nicotinic receptors are blocked by ฮฑ-Bungarotoxin ๐Ÿ and Curare (Tubocurarine) ๐Ÿ’€. Local anesthetics and drugs such as phencyclidine bind to these receptors to modulate action ๐Ÿ’Š.

Curare ๐Ÿ’€, a poison used by South American Indians in arrows prevents Ach from reaching post receptor area (occupies the sites) ๐Ÿšซ, since the muscles do not get activated ๐Ÿ’ชโŒ, this lead to blockade of all muscular responses. Since there is no post synaptic response, no nerve command is processed ๐Ÿง โŒ. This leads to total paralysis of muscles ๐Ÿ’€. Poison from cobra, Alpha bungarotoxin ๐Ÿ acts through this mechanism.

๐Ÿ„ b) Muscarinic Receptors

Muscarinic receptors are blocked by atropine (belladonna) ๐Ÿ’Š, and scopolamine ๐Ÿ’Š ๐Ÿ›‘.

Step 4๏ธโƒฃ: Presynaptic Receptor Blockade

Atropine ๐Ÿ’Š and scopolamine ๐Ÿ’Š block these ๐Ÿ›‘.

Step 5๏ธโƒฃ: Inhibition of Inactivation Activity

Inhibition of inactivation activity leads to increase in ACH in the brain by physostigmine ๐Ÿ’Š which blocks the acetylcholinesterase breaking down of Ach ๐Ÿ›‘. This leads to increased levels of Ach in the system โฌ†๏ธ, resulting in repeated stimulation of muscles ๐Ÿ’ชโšก. This means that the muscles would be repeatedly stimulated. This results in violent muscular contractions ๐Ÿ’ช๐Ÿ’ฅ.

๐ŸŒด West Indian Tribal Custom

It is reported by (Brown and Wallace, p 40) ๐Ÿ“š that there is a West Indian tribal custom where Calabar bean extract ๐Ÿซ˜ is used to find if a person is guilty or innocent โš–๏ธ. If guilty, then the person who had taken the bean extract as a test would die ๐Ÿ’€, and if they were innocent the person would swallow and vomit ๐Ÿคฎ.

๐Ÿฉบ Myasthenia Gravis Treatment

Physostigmine ๐Ÿ’Š is used as a therapy for Myasthenia Gravis ๐Ÿฉบ: (neurological disorder where the muscles are extremely weak ๐Ÿ’ชโฌ‡๏ธ, and don't have normal levels of ACH- for muscles to act). The drugs given increase ACH โฌ†๏ธ (cholinomimetics, or anticholinesterases). Increases in Ach using this therapy can lead to nightmares ๐Ÿ˜ฑ, confusion ๐Ÿค” and hallucination ๐ŸŒ€.

โšก Receptor Agonists

๐Ÿ„ a) Muscarinic Receptor Agonists

One of them is the muscarinic extract from poison mushrooms ๐Ÿ„, which if taken increases ACH activity โฌ†๏ธ leads to:

  • Increased sweating ๐Ÿ’ฆ
  • Increased salivation ๐Ÿ’ง
  • Constriction of pupils ๐Ÿ‘๏ธ
  • Decreased heart rate โค๏ธโฌ‡๏ธ

Also, muscarine ๐Ÿ„, which mimics the inhibitory effects of ACH (Agranoff 1989) ๐Ÿ“š.

๐Ÿšฌ b) Nicotinic Receptor Agonists

In neuromuscular joints, nicotine ๐Ÿšฌ mimics the excitatory effects of ACH โšก.

Nicotinic agonists could be useful in the treatment of a variety of neurological disorders including Alzheimer's disease ๐Ÿง , Parkinson's disease ๐Ÿค and chronic pain โš ๏ธ.

๐Ÿ›‘ Receptor Antagonists

๐Ÿ„ a) For Muscarinic Receptors

Atropine ๐Ÿ’Š is an antagonist for muscarinic receptors ๐Ÿ›‘. Atropine Belladonna ๐ŸŒธ- night shade poison- blocks muscarinic receptors, acts as a false transmitter ๐Ÿšซ. It occupies the post receptor sites and does not transmit message forward it cannot, it is a false molecule) ๐Ÿ”—โŒ.

Atropine belladonna liquid ๐Ÿ’ง leads to dilation of pupils ๐Ÿ‘๏ธ when applied directly on to the eyes. Why Belladonna (beautiful woman) ๐Ÿ‘ฉ because women used to apply it to their eyelids for wider eye look ๐Ÿ‘€. From Grecian times, Hippocrates used it for stomach ailments and cosmetics ๐Ÿบ. In 1880's, the breakdown of atropine from the belladonna plant ๐ŸŒธโ€“ affects the muscarinic receptor.

๐Ÿง  Memory Effects

Atropine ๐Ÿ’Š and Scopolamine ๐Ÿ’Š lead to decreased ACH in the brain leading to amnesia โฌ‡๏ธ๐Ÿง โŒ (reduced ACH in Alzheimer brain related to their memory loss ๐Ÿ“‰). This also indicates that ACH is involved in learning and memory ๐Ÿ“š.

๐Ÿ’Š Clinical Uses

Muscarinic antagonists are used to control and prevent vomiting ๐Ÿคฎโœ…, are also useful for the treatment of Parkinson's disease ๐Ÿค. In large doses however โฌ†๏ธ, the muscarinic antagonists cause severe side effects such as hallucinations ๐ŸŒ€ and memory disturbances ๐Ÿง โŒ.

Step 6๏ธโƒฃ: Choline Uptake

ฮฒ-Bungarotoxin ๐Ÿ and black spider widow venom ๐Ÿ•ท๏ธ affect choline uptake.

Check table 1 taken from the website ๐ŸŒ, it provides a very good summary of the agonists and antagonist we have referred to above ๐Ÿ“Š.

๐Ÿ“š References

  • Kalat, J.W. (1998). Biological Psychology. Brooks/ Cole Publishing
  • Carlson, N. R. (2005). Foundations of physiological psychology. Pearson Education New Zealand.
  • Pinel, J. P. (2003). Biopsychology. (5th ed). Allyn & Bacon Singapore.
  • Bloom, F., Nelson., & Lazerson. (2001), Behavioral Neuroscience: Brain, Mind and Behaviors. (3rd ed). Worth Publishers New York
  • Bridgeman, B. (1988). The Biology of Behavior and Mind. John Wiley & Sons, New York
  • Brown, T.S. & Wallace, P.S. (1980). Physiological Psychology. Academic Press, New York
  • Seigel, G. J., Agranoff, B.W, Albers W.R. & Molinoff, P.B. (1989). Basic Neurochemistry: Molecular, Cellular and Medical Aspects
  • Cooper, J.R., F.E Bloom, F. E., & Roth, R. H. (1970). The Biochemical basis of neuropharmacology (5th Ed.). New York, Oxford Univ. Press.